Local Recurrence After Hepatic Radiofrequency Coagulation
Top Cited Papers
- 1 August 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 242 (2) , 158-171
- https://doi.org/10.1097/01.sla.0000171032.99149.fe
Abstract
The purpose of this study was to analyze the factors that influence local recurrence after radiofrequency coagulation of liver tumors. Local recurrence rate varies widely between 2% and 60%. Apart from tumor size as an important risk factor for local recurrence, little is known about the impact of other factors. An exhaustive literature search was carried out for the period from January 1, 1990 to January 1, 2004. Only series with a minimal follow-up of 6 months and/or mean follow-up of 12 months were included. Univariate and multivariate meta-analyses were carried out. Ninety-five independent series were included, allowing the analysis of the local recurrence rate of 5224 treated liver tumors. In a univariate analysis, tumor-dependent factors with significantly less local recurrences were: smaller size, neuroendocrine metastases, nonsubcapsular location, and location away from large vessels. Physician-dependent favorable factors were: surgical (open or laparoscopic) approach, vascular occlusion, general anesthesia, a 1-cm intentional margin, and a greater physician experience. In a multivariate analysis, significantly less local recurrences were observed for small size (P < 0.001) and a surgical (versus percutaneous) approach (P < 0.001). Radiofrequency coagulation by laparoscopy or laparotomy results in superior local control, independent of tumor size. The percutaneous route should mainly be reserved for patients who cannot tolerate a laparoscopy or laparotomy. The short-term benefits of less invasiveness for the percutaneous route do not outweigh the longer-term higher risk of local recurrence.Keywords
This publication has 140 references indexed in Scilit:
- Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosisClinical Imaging, 2003
- Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablationThe Esophagus, 2003
- Power Rolloff During Interactive Radiofrequency Ablation Can Enhance Necrosis When Treating Hepatocellular CarcinomaAmerican Journal of Roentgenology, 2003
- Laparoscopic radiofrequency ablation of unresectable hepatic malignanciesSurgical Endoscopy, 2001
- Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approachesJournal of Gastrointestinal Surgery, 2001
- Destruction de tumeurs hépatiques malignes par radiofréquence. Expérience préliminaire à propos de 25 casAnnales de Chirurgie, 2001
- Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomyEuropean Journal of Surgical Oncology, 2000
- Laparoscopic radiofrequency ablation of primary and metastaticliver tumorsSurgical Endoscopy, 2000
- Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a ‘cooled-tip needle’. A preliminary clinical experienceEuropean Journal of Ultrasound, 1999
- Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer.American Journal of Roentgenology, 1996